Medarex, Inc. 2.25% Convertible Senior Notes due 2011 Purchase AgreementPurchase Agreement • May 4th, 2004 • Medarex Inc • Services-commercial physical & biological research • New York
Medarex, Inc. Registration Rights AgreementRegistration Rights Agreement • May 4th, 2004 • Medarex Inc • Services-commercial physical & biological research • New York
Medarex, Inc., a New Jersey corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) an aggregate of $150,000,000 principal amount of 2.25% Convertible Senior Notes due 2011 (“Convertible Notes”), convertible into shares of Common Stock, (the Convertible Notes and Common Stock are collectively referred to herein as “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
